Search

Palo Alto-based Anacor Pharmaceuticals filed for an IPO Friday evening, saying in a filing with the SEC that it is looking to raise up to $57.5M in an IPo on the Nasdaq Global Market. The firm is looking to list as "ANAC." The IPO is being underwritten by Morgan Stanley, Cowen and Company, Pacific Growth Equities, and Needham & Company. Anacor develops small-molecule therapeutics initially targeted at treating fungal, bacterial and inflammatory diseases. The firm is venture backed by Rho Ventures, Venrock Associates, Care Capital Investments, and Aberdare Ventures, among others.
posted on Friday, August 31, 2007

Related companies:
Anacor Pharmaceuticals

Related stories:
> Anacor Pharmaceuticals Gets Loan Funding
> Anacor Pharmaceuticals Files For IPO
> Anacor Pharmaceuticals Takes $50M More
> MAP Pharmaceuticals Files For IPO
> KaloBios Pharmaceuticals Files For IPO

---

silicontap.com Home